11-31403056-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_181706.5(DNAJC24):c.112-11755T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 151,928 control chromosomes in the GnomAD database, including 11,841 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.39 ( 11841 hom., cov: 32)
Consequence
DNAJC24
NM_181706.5 intron
NM_181706.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.157
Publications
5 publications found
Genes affected
DNAJC24 (HGNC:26979): (DnaJ heat shock protein family (Hsp40) member C24) Diphthamide is a unique posttranslationally modified histidine found only in translation elongation factor-2 (EEF2; MIM 130610). This modification is conserved from archaebacteria to humans and serves as the target for ADP-ribosylation and inactivation of EEF2 by diphtheria toxin (DT) and Pseudomonas exotoxin A. DPH4 is 1 of several enzymes involved in synthesis of diphthamide in EEF2 (Liu et al., 2004 [PubMed 15485916]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAJC24 | NM_181706.5 | c.112-11755T>G | intron_variant | Intron 2 of 4 | ENST00000465995.6 | NP_859057.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAJC24 | ENST00000465995.6 | c.112-11755T>G | intron_variant | Intron 2 of 4 | 1 | NM_181706.5 | ENSP00000417548.1 |
Frequencies
GnomAD3 genomes AF: 0.387 AC: 58818AN: 151810Hom.: 11817 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
58818
AN:
151810
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.388 AC: 58893AN: 151928Hom.: 11841 Cov.: 32 AF XY: 0.386 AC XY: 28662AN XY: 74258 show subpopulations
GnomAD4 genome
AF:
AC:
58893
AN:
151928
Hom.:
Cov.:
32
AF XY:
AC XY:
28662
AN XY:
74258
show subpopulations
African (AFR)
AF:
AC:
19386
AN:
41374
American (AMR)
AF:
AC:
6412
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
1443
AN:
3468
East Asian (EAS)
AF:
AC:
369
AN:
5180
South Asian (SAS)
AF:
AC:
1543
AN:
4822
European-Finnish (FIN)
AF:
AC:
4069
AN:
10540
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24299
AN:
67972
Other (OTH)
AF:
AC:
820
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1807
3615
5422
7230
9037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
681
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.